The EGLN genes are known to play a role in glucose metabolism through activation of HIF-2a, and this likely explains the association found between the EGLN SNPs and NAFLD (from metabolic syndrome) (74–76). The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatotic liver disease.